Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Apr;43(4):947-948.
doi: 10.1111/liv.15536. Epub 2023 Feb 17.

Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B

Affiliations
Comment

Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B

Chiuan-Bo Huang et al. Liver Int. 2023 Apr.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

REFERENCES

    1. Ohlendorf V, Wübbolding M, Gineste P, et al. Low anti-HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in HBe antigen-negative patients. Liver Int. 2022;00:1-9.
    1. Chi H, Li Z, Hansen BE, et al. Serum level of antibodies against hepatitis B Core protein is associated with clinical relapse after discontinuation of Nucleos(t)ide analogue therapy. Clin Gastroenterol Hepatol. 2019;17:182-191.
    1. Tseng CH, Hsu YC, Chang CY, et al. Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B. J Formos Med Assoc. 2018;117:915e921.
    1. Su T-H, Yang HC, Tseng TC, et al. Distinct relapse rates and risk predictors after discontinuing Tenofovir and Entecavir therapy. J Infect Dis. 2018;217:1193-1201.

LinkOut - more resources